|
OMIM |
Link |
Information gain |
01 |
|
panbronchiolitis, diffuse
|
[NCBI]
|
0.00637922
|
|
|
behcet syndrome
|
[NCBI]
|
0.00508553
|
|
|
alopecia areata 1
|
[NCBI]
|
0.00202126
|
|
|
EC1
|
[NCBI]
|
0.0014907
|
|
|
nasopharyngeal carcinoma 1
|
[NCBI]
|
0.00116849
|
|
|
IDDM
|
[NCBI]
|
0.00110372
|
|
|
MYMY1
|
[NCBI]
|
0.0010749
|
|
|
HLA-B
|
[NCBI]
|
0.000821184
|
|
|
CMM
|
[NCBI]
|
0.000565564
|
|
|
severe cutaneous adverse reaction, susceptibility to
|
[NCBI]
|
0.00044371
|
|
|
PSORS1
|
[NCBI]
|
0.000437807
|
|
|
human immunodeficiency virus type 1, susceptibility to
|
[NCBI]
|
0.000310698
|
|
|
MICA
|
[NCBI]
|
0.000306313
|
|
|
KIR3DL1
|
[NCBI]
|
0.000205438
|
|
|
MAFD1
|
[NCBI]
|
0.000198383
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
0.000155848
|
|
|
RA
|
[NCBI]
|
0.000144692
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
0.000133792
|
|
|
CF
|
[NCBI]
|
0.000121009
|
|
|
CVID
|
[NCBI]
|
0.000120402
|
|
|
persistent polyclonal b-cell lymphocytosis
|
[NCBI]
|
0.000114224
|
|
|
HSPA1L
|
[NCBI]
|
0.000104233
|
|
|
PDB1
|
[NCBI]
|
9.46325e-05
|
|
|
SCA1
|
[NCBI]
|
8.92755e-05
|
|
|
HFE
|
[NCBI]
|
8.76424e-05
|
|
|
KIR2DL1
|
[NCBI]
|
8.75667e-05
|
|
|
periodontitis, aggressive, 1
|
[NCBI]
|
8.43617e-05
|
|
|
nasopharyngeal carcinoma
|
[NCBI]
|
8.43617e-05
|
|
|
hepatitis b virus, susceptibility to
|
[NCBI]
|
7.45368e-05
|
|
|
takayasu arteritis
|
[NCBI]
|
7.20374e-05
|
|
|
amyloidosis, primary cutaneous
|
[NCBI]
|
6.77559e-05
|
|
|
omenn syndrome
|
[NCBI]
|
6.58926e-05
|
|
|
KIR2DL2
|
[NCBI]
|
6.38362e-05
|
|
|
TNF
|
[NCBI]
|
6.18506e-05
|
|
|
PDB
|
[NCBI]
|
5.84112e-05
|
|
|
hodgkin lymphoma
|
[NCBI]
|
5.84112e-05
|
|
|
CCAL2
|
[NCBI]
|
5.71823e-05
|
|
|
HLA-A
|
[NCBI]
|
5.58831e-05
|
|
|
HLA-C
|
[NCBI]
|
5.44144e-05
|
|
|
LFS1
|
[NCBI]
|
5.38705e-05
|
|
|
cerebrotendinous xanthomatosis
|
[NCBI]
|
4.92942e-05
|
|
|
SPDA1
|
[NCBI]
|
4.84878e-05
|
|
|
CDSN
|
[NCBI]
|
4.84309e-05
|
|
|
LSA
|
[NCBI]
|
4.77116e-05
|
|
|
LTA
|
[NCBI]
|
4.23946e-05
|
|
|
kita-kyushu lung cancer antigen 1
|
[NCBI]
|
4.21136e-05
|
|
|
TRAPPC1
|
[NCBI]
|
4.21136e-05
|
|
|
BAT4
|
[NCBI]
|
4.21136e-05
|
|
|
minor histocompatibility antigen hb-1
|
[NCBI]
|
4.21136e-05
|
|
|
BAT5
|
[NCBI]
|
4.21136e-05
|
|
|
BCPM
|
[NCBI]
|
4.12359e-05
|
|
|
complement component 2 deficiency
|
[NCBI]
|
4.10469e-05
|
|
|
HLA8
|
[NCBI]
|
3.46921e-05
|
|
|
SCZD
|
[NCBI]
|
3.28139e-05
|
|
|
P2RX5
|
[NCBI]
|
3.18922e-05
|
|
|
IGLP1
|
[NCBI]
|
3.18922e-05
|
|
|
JMML
|
[NCBI]
|
3.14328e-05
|
|
|
BAT3
|
[NCBI]
|
3.00746e-05
|
|
|
HLA-MT
|
[NCBI]
|
3.00746e-05
|
|
|
SLE
|
[NCBI]
|
2.94103e-05
|
|
|
EHMT2
|
[NCBI]
|
2.87236e-05
|
|
|
KIR3DL2
|
[NCBI]
|
2.87236e-05
|
|
|
KIR2DL3
|
[NCBI]
|
2.76474e-05
|
|
|
KIR2DL4
|
[NCBI]
|
2.67528e-05
|
|
|
LST1
|
[NCBI]
|
2.67528e-05
|
|
|
BAT1
|
[NCBI]
|
2.59872e-05
|
|
|
TAPBP
|
[NCBI]
|
2.59872e-05
|
|
|
CPI
|
[NCBI]
|
2.55336e-05
|
|
|
MS
|
[NCBI]
|
2.37276e-05
|
|
|
ALPS
|
[NCBI]
|
2.1908e-05
|
|
|
MYB
|
[NCBI]
|
2.11716e-05
|
|
|
EV
|
[NCBI]
|
2.06239e-05
|
|
|
MG
|
[NCBI]
|
1.88993e-05
|
|
|
HLA-DRA
|
[NCBI]
|
1.65242e-05
|
|
|
C4A
|
[NCBI]
|
1.59642e-05
|
|
|
F13A1
|
[NCBI]
|
1.49994e-05
|
|
|
CFB
|
[NCBI]
|
1.49994e-05
|
|
|
FOXP3
|
[NCBI]
|
1.41879e-05
|
|
|
BL
|
[NCBI]
|
1.09737e-05
|
|
|
CD
|
[NCBI]
|
1.08175e-05
|
|
|
IFNA1
|
[NCBI]
|
1.03181e-05
|
|
|
IL6
|
[NCBI]
|
9.16844e-06
|
|
|
VEGF
|
[NCBI]
|
9.01463e-06
|
|
|
FGFR3
|
[NCBI]
|
7.50388e-06
|
|
|
polycystic kidneys
|
[NCBI]
|
6.33476e-06
|
|
|
ALD
|
[NCBI]
|
5.07123e-06
|
|
|
temporal arteritis
|
[NCBI]
|
4.16164e-06
|
|
|
PRL
|
[NCBI]
|
3.21209e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
1.87243e-06
|
|
|
CEACAM5
|
[NCBI]
|
8.85779e-07
|
|
|
FMF
|
[NCBI]
|
8.66324e-07
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
6.64387e-07
|
|
|
CFTR
|
[NCBI]
|
1.7297e-07
|
|
|
AR
|
[NCBI]
|
9.37292e-09
|
|
|
MBP
|
[NCBI]
|
7.02167e-10
|
|